Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

BIOFORCE NANOSCIENCES HOLDINGS, INC. logo
BFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC.

MaveScore 45 Low model confidence
Last Price US$1.38 As of Jun 15, 2026
Market Cap US$25.5m Company size context
7D Performance 26.61% Past 7 days
1Y Performance 137.93% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Dec 31, 2025

167 days old

Market price date

Jun 15, 2026

1 day old

Coverage

15/16

1 missing model inputs

Data quality

Excellent

Current stored snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 45 Low confidence

Stored data quality

Freshness and coverage checks

Latest stored fundamentals and price inputs are recent enough for normal research review.

15/16 Current stored snapshot

Quality

Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

8/35 Weak

Financial Strength

Financial strength rewards durable profitability, margins, and positive free cash flow.

14/25 Mixed

Valuation Support

Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

8/15 Mixed

Momentum

Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

15/15 Strong

Shareholder Alignment

Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

0/10 Weak

Positive model output

  • Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

Research risks to review

  • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
  • Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include free cash flow per share.

Dashboard Funda..tals Deep..lue Prediction Screener Map

BIOFORCE NANOSCIENCES HOLDINGS, INC. Overview

Industry: Packaged Foods

Sector: Consumer Defensive

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online under the BioForce Eclipse brand, as well as through social media and telemarketing. BioForce Nanosciences Holdings, Inc. was incorporated in 1999 and is based in Virginia Beach, Virginia.

BIOFORCE NANOSCIENCES HOLDINGS, INC. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review BIOFORCE NANOSCIENCES HOLDINGS, INC. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



BIOFORCE NANOSCIENCES HOLDINGS, INC. Competitors

BIOFORCE NANOSCIENCES HOLDINGS, INC. operates in the Packaged Foods industry within the Consumer Defensive sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

BIOFORCE NANOSCIENCES HOLDINGS, INC.

US$1.38

US$25.5m

26.61%

137.93%